Mullerian Inhibiting Substance inhibits invasion and migration of epithelial cancer cell lines

Gynecologic Oncology

Volumn 120, Issue 1, 2011, Pages 128-134

  Chang, Henry L ^a,b   Pieretti Vanmarcke, Rafael ^a   Nicolaou, Fotini ^a   Li, Xianlin ^a   Wei, Xiaolong ^a   MacLaughlin, David T ^a   Donahoe, Patricia K ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

Author keywords

Anti Mullerian hormone; Cell invasion; Cell migration; Mullerian Inhibiting Substance

Indexed keywords

MUELLERIAN INHIBITING FACTOR;

ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CELL ASSAY; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CHICK EMBRYO; CONTROLLED STUDY; EMBRYO; EPITHELIUM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; METASTASIS; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTI-MULLERIAN HORMONE; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CHICK EMBRYO; CHORIOALLANTOIC MEMBRANE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FIBROSARCOMA; HEAD AND NECK NEOPLASMS; HUMANS; NEOPLASM INVASIVENESS; NEOPLASMS; OVARIAN NEOPLASMS; PACLITAXEL; RECEPTORS, PEPTIDE; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA;

EID: 78649905128     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2010.09.017     Document Type: Article

References (45)

1. P.T. Masiakos, D.T. MacLaughlin, S. Maheswaran, J. Teixeira, A.F. Fuller Jr., and P.C. Shah Human ovarian cancer, cell lines, and primary ascites cells express the human Mullerian Inhibiting Substance (MIS) type II receptor, bind, and are responsive to MIS Clin Cancer Res 7 1999 3488 3499
2. D.L. Segev, T.U. Ha, T.T. Tran, M. Kennealy, P. Harkin, and M. Jung Mullerian Inhibiting Substance inhibits breast cancer cell growth through an NFkappa B-mediated pathway J Biol Chem 275 2000 28371 28379
3. D.L. Segev, Y. Hoshiya, M. Hoshiya, T.T. Tran, J.L. Carey, and A.E. Stephen Mullerian Inhibiting Substance regulates NF-kappa B signaling in the prostate in vitro and in vivo Proc Natl Acad Sci 99 2002 239 244
4. R. Pieretti-Vanmarcke, P.K. Donahoe, L.A. Pearsall, D.M. Dinulescu, D.C. Connelly, and E.F. Halpern Mullerian Inhibiting Substance enhances subclinical doses of chemotherapeutic agents to inhibit human and mouse ovarian cancer Proc Natl Acad Sci 103 2006 17426 17431
5. J. Teixeira, S. Maheswaran, and P.K. Donahoe Mullerian Inhibiting Substance: an instructive developmental hormone with diagnostic and possible therapeutic applications Endocr Rev 22 2001 657 674
6. A. Hayashi, P.K. Donahoe, G.P. Budzik, and R.L. Trelstad Periductal and matrix glycosaminoglycans in rat Mullerian duct development and regression Dev Biol 92 1982 16 26
7. H.B. Austin DiI analysis of cell migration during Mullerian duct regression Dev Biol 169 1995 29 36
8. Y. Zhan, A. Fujino, D.T. MacLaughlin, T.F. Manganaro, P.P. Szotek, and N.A. Arango Mullerian Inhibiting Substance regulates its receptor/SMAD signaling and causes mesenchymal transition of the coelomic epithelial cells early in Mullerian duct regression Development 133 2006 2359 2369
9. A. Fujino, N.A. Arango, Y. Zhan, T.F. Manganaro, X. Li, and D.T. MacLaughlin Cell migration and activated PI3K/AKT-directed elongation in the developing rat Müllerian duct Dev Biol 325 2 2009 Jan 15 351 362
10. W.M. Baarends, J.M. van Helmond, M. Post, P.J. van der School, J.W. Hoogerbrugge, and J.P. de Winter A novel member of the transmembrane serine/threonine kinase receptor family is specifically expressed in the gonads and in mesenchymal cells adjacent to the Mullerian duct Development 120 1994 189 197
11. N. DiClemente, C. Wilson, E. Faure, L. Boussin, P. Carmillo, and R. Tizard Cloning, expression, and alternative splicing of the receptor for anit-Mullerian hormone Mol Endocrinol 8 1994 1006 1020
12. J. Teixeira, W.W. He, P.C. Shah, N. Morikawa, M.M. Lee, and E.A. Catlin Developmental expression of a candidate Mullerian Inhibiting Substance type II receptor Endocrinology 137 1996 160 165
13. Y. Mishina, R. Tizard, J.M. Deng, B.G. Pathak, N.G. Copeland, and N.A. Jenkins Sequence, genomic organization and chromosomal location of the mouse Mullerian Inhibiting Substance type II receptor gene Biochem Res Commun 237 1997 741 746
14. S. Imbeaud, E. Faure, I. Lamarre, M.G. Mattei, N. di Clemente, and R. Tizard Insensitivity to anti-Mullerian hormone due to a mutation in the human anti-Mullerian hormone receptor Nat Genet 11 1995 382 388
15. M. Tsuji, H. Shima, C.Y. Yonemura, J. Brody, P.K. Donahoe, and G.R. Cunha Effect of human recombinant Mullerian Inhibiting Substance on isolated epithelial and mesenchymal cells during Mullerian duct regression in the rat Endocrinology 131 1992 1481 1488
16. N. Josso, C. Belville, N. di Clemente, and Y.P. Picard AMH and AMH receptor defects in persistent Mullerian duct syndrome Hum Reprod Update 11 2005 351 356 Review
17. M. Hoshiya, B. Christian, W. Cromie, Y. Zhan, D.T. MacLaughlin, and P.K. Donahoe Persistent Mullerian duct syndrome with a deletion and a novel splicing Mutation in the MIS type II receptor Birth Defects Res 67 2003 868 874
18. J. Teixeira, E. Fynn-Thompson, A. Payne, and P.K. Donahoe Müllerian-inhibiting substance regulates androgen synthesis at the transcriptional level Endocrinology 140 1999 4732 4738
19. V. Sriraman, E. Niu, J.R. Matias, P.K. Donahoe, D.T. MacLaughlin, and M.P. Hardy Müllerian inhibiting substance inhibits testosterone synthesis in adult rats J Androl 22 2001 750 758
20. A.M. Trbovich, P.M. Sluss, V.M. Laurich, F.H. O'Neill, D.T. MacLaughlin, and P.K. Donahoe Mullerian Inhibiting Substance lowers testosterone in luteinizing hormone-stimulated rodents Proc Natl Acad Sci USA 98 2001 3393 3397
21. M.M. Lee, C.C. Seah, P.T. Masiakos, C.M. Sottas, F. Preffer, and P.K. Donahoe Mullerian Inhibiting Substance type II receptor expression and function in purified rat Leydig cells Endocrinology 140 1999 2819 2827
22. J.H. Kim, M.M. Seibel, D.T. MacLaughlin, P.K. Donahoe, B.J. Ransil, and P.A. Hametz The inhibitory effects of Müllerian Inhibiting Substance on epidermal growth factor induced proliferation and progesterone production of human granulosa-luteal cells J Clin Endocrinol Metab 75 1992 911 917
23. E.J. Renaud, D.T. MacLaughlin, E. Oliva, B.R. Rueda, and P.K. Donahoe Endometrial cancer is a receptor mediated target for Mullerian Inhibiting Substance Proc Natl Acad Sci USA 102 2005 111 116
24. Erratum in: Proc Natl Acad Sci USA 102 2005 6513
25. Y. Hoshiya, V. Gupta, D.L. Segev, M. Hoshiya, J.L. Carey, and L.M. Sasur Mullerian substance induces NFkB signaling in breast and prostate cancer cells Mol Cell Endocrinol 211 2003 43 49
26. V. Gupta, J.L. Carey, H. Kawakubo, A. Muzikansky, J.E. Green, and P.K. Donahoe Mullerian Inhibiting Substance suppresses tumor growth in the C3(1)T antigen transgenic mouse mammary carcinoma model Proc Natl Acad Sci USA 102 2005 3219 3224
27. P.Y. Wang, K. Koishi, A.B. McGeachie, M. Kimber, D.T. MacLaughlin, and P.K. Donahoe Mullerian Inhibiting Substance acts as a motor neuron survival factor in vitro Proc Natl Acad Sci USA 102 2005 16421 16425
28. J.N. Bakkum-Gamez, G. Aletti, K.A. Lewis, G.L. Keeney, B.M. Thomas, and I. Navarro-Teulon Müllerian Inhibiting Substance type II receptor (MISIIR): a novel, tissue-specific target expressed by gynecologic cancers Gynecol Oncol 108 1 2008 Jan 141 148
29. J.Y. Song, K.Y. Chen, S.Y. Kim, M.R. Kim, K.S. Ryu, and J.H. Cha The expression of Müllerian Inhibiting Substance/anti-Müllerian hormone type II receptor protein and mRNA in benign, borderline and malignant ovarian neoplasia Int J Oncol 34 6 2009 Jun 1583 1591
30. T. Chin, R.L. Parry, and P.K. Donahoe Human Müllerian Inhibiting Substance inhibits tumor growth in vitro and in vivo Can Res 51 1991 2101 2106
31. A.E. Stephen, L.A. Pearsall, B.P. Christian, P.K. Donahoe, J.P. Vacanti, and D.T. MacLaughlin Highly purified Mullerian Inhibiting Substance inhibits ovarian cancer in vivo Clin Can Res 8 2002 2640 2646
32. W.W. He, M.L. Gustafson, S. Hirobe, and P.K. Donahoe The developmental expression of four novel serine/threonine kinase receptors homologous to the activin/TGF-b II receptor family Dev Dyn 196 1993 133 142
33. Z. Gu, E.M. Reynolds, J. Song, H. Lei, L. Yu, and W. He The type I serine/threonine kinase receptor ActRIA (ALK 2) is required for gastrulation of the mouse embryo Development 26 1999 2551 2561
34. L. Gouedard, Y.G. Chen, L. Thevenet, C. Racine, S. Borie, and I. Lamarre Engagement of bone morphogenetic protein type IB receptor and Smad1 signaling by anti-Mullerian hormone and its type II receptor J Biol Chem 2000 275-27973-78
35. J.A. Visser, R. Olaso, M. Verhoef-Post, P. Kramer, A.P.N. Themmen, and H.A. Ingraham The serine/threonine transmembrane receptor ALK2 mediates Mullerian Inhibiting Substance signaling Mol Endocrinol 15 2001 936 945
36. S. Jamin, N.A. Arango, Y. Mishina, M.C. Hanks, and R.R. Behringer Requirement of BMPR1a for Mullerian duct Clarke TR, Hoshiya Y, Yi SE, Liu X, Lyons KM, and Donahoe PK. Müllerian Inhibiting Substance signaling uses a BMP-like pathway mediated by ALK2 and induces Smad6 expression Mol Endocrinol 15 2001 946 995
37. T.R. Clarke, Y. Hoshiya, S.E. Yi, K. Liu, K.M. Lyons, and P.K. Donahoe Mullerian Inhibiting Substance signaling uses a bone morphogenetic protein (BMP)-like pathway mediated by ALK2 and induces SMAD6 expression Mol Endocrinol 15 2001 946 959
38. A. Zijlstra, R. Mellor, G. Panzarella, R.T. Aimes, J.D. Hooper, and N.D. Marchenko A quantitative analysis of rate-limiting steps in the metastatic cascade using human-specific real-time polymerase chain reaction Cancer Res 62 2002 7083 7092
39. M. Loscertales, A. Mikels, J. Kuang-Hsein Hu, P.K. Donahoe, and D.J. Roberts Chick pulmonary Wnt5a directs airway and vascular tubulogenesis Development 135 7 2008 1365 1376
40. P.K. Donahoe, Y. Ito, and W.H. Hendren 3rd A graded organ culture assay for the detection of Mullerian Inhibiting Substance J Surg Res 23 2 1977 141 148
41. L. Gouédard, Y. Chen, L. Thevenet, C. Racine, S. Borie, and I. Lamarre Engagement of bone morphogenetic protein type IB receptor and Smad1 signaling by anti-Müllerian hormone and its type II receptor J Biol Chem 275 2000 27973 27978
42. K. Miyazono, and K. Miyazawa Id: a target of BMP signaling Sci STKE 2002 pe40
43. A.J. Ross, C. Tilman, H. Yao, D.T. MacLaughlin, and B. Capel AMH induces mesonephric cell migration in XX gonads Mol Cell Endocrinol 211 2003 1 7
44. P.P. Szotek, R. Pieretti-Vanmarcke, P.T. Masiakos, D.M. Dinulescu, D. Connolly, and R. Foster Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian Inhibiting Substance responsiveness Proc Natl Acad Sci 103 2006 11154 11159
45. X. Wei, D. David Dombkowski, K. Meirelles, R. Pieretti-Vanmarcke, P.P. Szotek, and H.L. Chang Mullerian Inhibiting Substance preferentially inhibits stem/cell progenitors in human ovarian cancer cell lines compared with chemotherapeutics PNAS 107 44 2010 18874 18879